MARATTO

article · Microbial Drug Resistance

A Multicenter Surveillance of Antimicrobial Resistance Among <i>Pseudomonas aeruginosa</i> in Hospitals of the Greater Accra Region of Ghana

Abstract

MDR <i>P. aeruginosa</i> and carbapenem Resistant <i>P.aeruginosa</i> (CRPA), mostly <i>blaNDM-1</i> producers, are major causes of infection in our setting. Restricting carbapenem use through stewardship and strengthening infection control is essential to limit CRPA spread.

Research topics

  • Antibiotic Resistance in Bacteria
  • Antibiotic Use and Resistance
  • Infections and bacterial resistance

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.1177/10766294261436119

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.